Duopharma Biotech Bhd 2025 IR
The report highlights Duopharma Biotech Berhad's financial and sustainability performance for the fiscal year 2025. The company achieved a 14.5% increase in revenue to RM931.69 million and a 43.6% surge in profit before tax to RM114.91 million. Key achievements include obtaining the first-ever halal certification from JAKIM for a biosimilar erythropoietin (ERYSAA_x0000_) and receiving EU GMP certification for its highly potent active pharmaceutical ingredients (HAPI) plant. On the environmental front, the company reduced its Scope 1 and 2 greenhouse gas emissions intensity by 14% year-on-year and generated 3.2 GWh of solar power across its manufacturing sites.
Company: Duopharma Biotech Bhd
Sector: Health Care
Country: Malaysia
Year: 2025
Type: IR
Pages: 272
Duopharma Biotech Bhd
Integrated Annual Report
The report highlights Duopharma Biotech Berhad's financial and sustainability performance for the fiscal year 2025. The company achieved a 14.5% increase in revenue to RM931.69 million and a 43.6% surge in profit before tax to RM114.91 million. Key achievements include obtaining the first-ever halal certification from JAKIM for a biosimilar erythropoietin (ERYSAA_x0000_) and receiving EU GMP certification for its highly potent active pharmaceutical ingredients (HAPI) plant. On the environmental front, the company reduced its Scope 1 and 2 greenhouse gas emissions intensity by 14% year-on-year and generated 3.2 GWh of solar power across its manufacturing sites.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees